Lung Cancer on Immunotherapy: Melatonin Dosing for Sleep, Fatigue, and Immune Support During Checkpoint Inhibitor Treatment

Fatigue and sleep disruption affect a large proportion of people on checkpoint inhibitor therapy for lung cancer. This article reviews how melatonin has been studied, which dose ranges have clinical data behind them, and what questions to raise with your care team.